AnodyneWiki

α-Ethyltryptamine

αET
α-Ethyltryptamine
Salts
[]
α-Ethyltryptamine hydrochloride
α-Ethyltryptamine hydrochloride
α-Ethyltryptamine acetate
α-Ethyltryptamine acetate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass188.27 g/mol [1]
Melting point221 [1]
Solubility510 mg/L [1]
Predicted LogP2.5 [1]
Structural Identifiers
[]
Molecular formulaC12H16N2
IUPAC name1-(1H-indol-3-yl)butan-2-amine
SMILESCCC(CC1=CNC2=CC=CC=C21)N
InChIInChI=1S/C12H16N2/c1-2-10(13)7-9-8-14-12-6-4-3-5-11(9)12/h3-6,8,10,14H,2,7,13H2,1H3
InChIKeyZXUMUPVQYAFTLF-UHFFFAOYSA-N
CAS number2235-90-7
UNIIGR181O3R32
PubChem CID8367
Pharmacokinetics[]
Onset0.5–1.5 hours
Elimination half-life~8 hours
Duration of action6–8 hours (100–150 mg)
MetabolismHydroxylation
ExcretionUrine (majority)
Routes of administrationOral

α-Ethyltryptamine (also known as Etryptamine, 3-(2-Aminobutyl)indole, Etriptamina, 3-Indolylbutylamine, Etryptaminum, Monase, Ro 3-1932, 1H-Indole-3-ethanamine, α-ethyl-, 2-ethyltryptamine or 3-(2-aminobutylindole)) is a entactogen and stimulant substance of the α-alkyltryptamine class.

Chemistry

Salts []

α-Ethyltryptamine is typically found in the form of its hydrochloride and acetate salts.

 []

α-Ethyltryptamine is a racemic mixture of the (optical activity ( + / - )).

Stereoisomers from PubChem

α-Ethyltryptamine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The mechanism of action responsible for its antidepressant activity was believed to lie in its ability to inhibit monoamine oxidase, while its stimulant activity on the central nervous system appeared to result from its structural similarity to indole-based psychedelics. [5] Research discovered αET to be both a monoamine oxidase inhibitor and a potent monoamine releasing agent capable of serotonergic neurotoxicity. [3] The ability to release serotonin was linked to αET's MDMA like properties. [2] αET has been shown to release serotonin pre-synaptically, as well as lesser amounts of norepinephrine and dopamine. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

shared target3 (3 contraindicated)

Subjective effects []

 []

  • Brazil: α-Ethyltryptamine is a F2.[3]
  • Canada: α-Ethyltryptamine is a Schedule III.
  • United States: α-Ethyltryptamine is a Schedule I under the "Controlled Substances Act".
  • United Kingdom: α-Ethyltryptamine is a Class A under the "Misuse of Drugs Act 1971".
  • Germany: α-Ethyltryptamine is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
  • United Nations: α-Ethyltryptamine is a Schedule I psychotropic under the "Convention on Psychotropic Substances 1971".

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 8367, α-Ethyltryptamine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/8367
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. α-Ethyltryptamine. UNII: GR181O3R32. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GR181O3R32
  3. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 14:59:59
drugspromissing (no DrugsPRO reagent data)2026-11-20 14:59:55
erowidmissing (no Erowid substance of that name)2026-11-20 14:59:55
gsrsok2026-11-20 14:59:57
hmdbmissing (no HMDB id)2026-11-20 14:59:55
keggok2026-11-20 14:59:59
pubchemok2026-11-20 14:59:53
redditmissing (no r/tripreports posts mention it)2026-11-20 14:59:55
sidermissing (not in SIDER)2026-11-20 14:59:55
structureok2026-11-20 14:59:55
wikipediaok2026-11-20 14:59:55